To Rebuild Zicam, Matrixx Can Tap Into Brand's History, Pharmacists' Regard

Matrixx Initiatives' best chances for rebuilding the Zicam brand appear to be reminding consumers why they initially chose the firm's products and tapping pharmacists' insight on the efficacy of zinc-containing cold remedies

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet